Google Search Appliance

Search Results

Results 51 - 60 of about  212.  Search took: 0.10 seconds.

Sort by date / Sort by relevance
You Searched For: vascular

... Products segment. Vascular Products — Worldwide sales of coronary, endovascular and vessel closure products. Abbott's ...
www.abbott.com/../microsite/annual_report/2010/10_note_6.html - 34k - 2011-09-12

... 14.7. Vascular a, 282, 478, 760, (24.6) a, 8.1, 5.7, (6.8) a, (8.1) a. ... 15.7. Vascular b, 1,226, 1,845, 3,071, (20.7) b, 7.6, 3.3, (5.6) b, (7.9) b. ...
www.abbott.com/.. - 110k - 2013-01-31

... Innovation-driven device businesses Vascular, molecular diagnostics, vision care Durable growth businesses Established pharmaceuticals ...
www.abbott.com/../Citizenship/Reports/GCR10-Ireland-14.pdf - 215k - 2011-09-16

... Available 24 hours, 7 days a week. Abbott Vascular. (800) 227-9902. ... Available 24 hours, 7 days a week. Abbott Vascular. (800) 227-9902. ...
www.abbott.com/../0:0/general_content/General_Content_00138.htm - 58k - 2013-05-29

... as a result of the approval to market the Xience V drug-eluting stent in Japan, resulting in an increase in goodwill in the Vascular Products segment. ...
www.abbott.com/../annual_report/2010/13_note_11-15.html - 35k - 2011-09-12

... Page 14. Medical Devices Robust Vascular Pipeline: Absorb ... Page 15. Medical Devices Robust Vascular Pipeline: MitraClip ...
phx.corporate-ir.net/.. - 105k - 2013-01-07

... Diagnostics —. Immunochemistry. 3,150. 8. 2,904. 4. 2,798. (2). Vascular Products —. Coronary Stents. 2,078. 4. 2,007. 24. 1,618. 35. ...
www.abbott.com/../microsite/annual_report/2011/20_review3.php - 60k -

... medical devices • Vascular, Diabetes, Vision Care • Est. 2 yrs ago ... After ~ 2 years Medical Devices Vascular: Absorb bioresorbable vascular scaffold ...
phx.corporate-ir.net/.. - 122k - 2013-06-11

... Vascular, 374, 452, 826, (6.3), 4.5, 7.0, (0.7), 0.6. Diabetes Care, 136, 215, 351, 7.1, 1.5, 2.2, 3.5, 4.0. ... Vascular, 1,547, 1,786, 3,333, (6.9), 10.0, 16.6, ...
www.abbott.com/news-media/press-releases/2012-january25.htm - 110k - 2013-01-11

... as a result of the approval to market the Xience V drug-eluting stent in Japan, resulting in an increase in goodwill in the Vascular Products segment. ...
www.abbott.com/../annual_report/2011/14_note_11-14.php - 43k -


Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next